Purdue Pharma LP et al. v. Collegium Pharmaceutical, Inc. (15-cv-13099).

  • October 9, 2018

The U.S. Patent and Trademark Office has announced that they will remain open for business as usual during the shutdown, running on fees collected over the past year. They anticipate this lasting a few weeks, at which point they would be forced to shut down the bulk of their operations, remaining open to accept new applications but not actually examining applications.

By submitting this form, you are consenting to receive marketing emails from: Lando & Anastasi, LLP. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


How can we help you?